For travel guidance and temperature management, check our peptide storage guide
The FDA has approved semaglutide for: Type 2 diabetes management (under brand names like Ozempic) Weight management in adults with obesity or overweight with at least one weight-related condition (under brand names like Wegovy) The medication is administered as a once-weekly injection, with dosages gradually increasing over time to minimize side effects and allow the body to adjust to the treatment
individuals who were first prescribed liraglutide (38.2%) switched after a median of 7.3 months, while those who were prescribed exenatide (2%), dulaglutide (18.3%), semaglutide (39.5%) and tirzepatide (2%) switched after a median of 6.8, 5.9, 3.5 and 2.8 months, respectively (P=0.007)
Always communicate any side effects with your healthcare provider to ensure the best possible treatment outcomes
The timeline above shows what an average Wegovy weight loss journey might look like, but individual results can vary depending on how your body responds to treatment